Skip to content

Safety of the PET-511BTM Transesophageal Transducer

Safety of the PET-511BTM Transesophageal Transducer (TEE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00997568
Acronym
TEE
Enrollment
50
Registered
2009-10-19
Start date
2009-10-31
Completion date
Unknown
Last updated
2010-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Requiring TEE Procedure by Their Physician

Keywords

transesophageal, transducer, TEE

Brief summary

The purpose of this study is to demonstrate the safety of the redesigned transesophageal echocardiogram (TEE) transducer as it is inserted and transitioned into the esophagus through the mouth.

Detailed description

The PET-511BTM is a multiplane transesophageal transducer designed for use with Toshiba Diagnostic Ultrasound Systems for the visualization of the heart (and other organs) as a real-time ultrasound image. It is inserted into the esophagus through the mouth to visualize a plane of the heart through the esophageal wall. The objective of the study is to demonstrate the safe use of the redesigned Toshibal TEE transducer for ease of passage and during transitioning into and down the esophagus to complete a normal TEE study.

Interventions

DEVICEPET-511BTM

Transesophageal Transducer

Sponsors

Toshiba America Medical Systems, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female patients between the ages of 20 and 80 * Informed consent understood and signed * Compliance with post-treatment follow-up protocol requirements

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
The TEE transducer passes safely into the esophagus.during, 30 minutes, and 24 hours after the exam

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026